Glyburide Tablets
Company: Roche
Approval Status: Approved December 1997
Treatment for: blood-glucose lowering agent
Areas: Endocrinology; Hematology
Possible similar drugs: Glyburide Tablets; Glyburide Tablets
General Information
Other Useful Resources
Klonopin has been approved in a lypophilized wafer formula for 0.125mg, 0.25mg, 0.5mg, 1mg, and 2mg strengths.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
